Literature DB >> 15039303

Chlamydial persistence: beyond the biphasic paradigm.

Richard J Hogan1, Sarah A Mathews, Sanghamitra Mukhopadhyay, James T Summersgill, Peter Timms.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15039303      PMCID： PMC375192          DOI： 10.1128/IAI.72.4.1843-1855.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  110 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).

Authors:  Karuna P Karunakaran; James F Blanchard; Ausra Raudonikiene; Caixia Shen; Andrew D Murdin; Robert C Brunham
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse.

Authors:  T C Moazed; C C Kuo; J T Grayston; L A Campbell
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

4.  Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections.

Authors:  Richard J Hogan; Sarah A Mathews; Andrei Kutlin; Margaret R Hammerschlag; Peter Timms
Journal:  Microb Pathog       Date:  2003-01       Impact factor: 3.738

5.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

6.  Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

7.  Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates.

Authors:  Harlan D Caldwell; Heidi Wood; Debbie Crane; Robin Bailey; Robert B Jones; David Mabey; Ian Maclean; Zeena Mohammed; Rosanna Peeling; Christine Roshick; Julius Schachter; Anthony W Solomon; Walter E Stamm; Robert J Suchland; Lacey Taylor; Sheila K West; Tom C Quinn; Robert J Belland; Grant McClarty
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

8.  Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Prospective study of perinatal transmission of Chlamydia trachomatis.

Authors:  J Schachter; M Grossman; R L Sweet; J Holt; C Jordan; E Bishop
Journal:  JAMA       Date:  1986-06-27       Impact factor: 56.272

10.  Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence.

Authors:  W L Beatty; T A Belanger; A A Desai; R P Morrison; G I Byrne
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441
View more
  143 in total

Review 1.  Exit from dormancy in microbial organisms.

Authors:  Jonathan Dworkin; Ishita M Shah
Journal:  Nat Rev Microbiol       Date:  2010-10-25       Impact factor: 60.633

Review 2.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 3.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

Review 4.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

5.  Chlamydial GroEL autoregulates its own expression through direct interactions with the HrcA repressor protein.

Authors:  Adam C Wilson; Christine C Wu; John R Yates; Ming Tan
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

6.  Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response.

Authors:  Sanghamitra Mukhopadhyay; Richard D Miller; Erin D Sullivan; Christina Theodoropoulos; Sarah A Mathews; Peter Timms; James T Summersgill
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Authors:  K Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; K A Fields
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

8.  The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis.

Authors:  Narae Park; Kinrin Yamanaka; Dat Tran; Pete Chandrangsu; Johnny C Akers; Jessica C de Leon; Naomi S Morrissette; Michael E Selsted; Ming Tan
Journal:  J Antimicrob Chemother       Date:  2008-10-27       Impact factor: 5.790

9.  CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract.

Authors:  M King; H Poya; J Rao; S Natarajan; A W Butch; N Aziz; S Kok; M H Chang; J M Lyons; K Ault; K A Kelly
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245

Review 10.  Chlamydia trachomatis today: treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesis.

Authors:  D Dean
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.